Explore preclinical research on GHK-Cu copper peptide, covering collagen synthesis, wound healing models, anti-fibrotic signaling, and gene expression data.
Preclinical research on Selank explores GABA-A modulation, anxiolytic effects in rodent stress models, and BDNF upregulation without dependence or tolerance.
Explore preclinical research on MOTS-c peptide, the mitochondrial-derived peptide encoded in 12S rRNA linked to glucose homeostasis and AMPK activation.
Explore 2026 preclinical research on oral peptides metabolic effects — GLP-1, BPC-157, MOTS-c, and NAD+ data from rodent animal model studies reviewed here.
Explore preclinical animal model data on oral GLP-1 appetite regulation, covering food intake, satiety hormones, and hypothalamic GLP-1R activation research.
Preclinical studies on BPC-157 arginate vs acetate salt forms examine degradation rates, pH stability, and oral delivery behaviour in research models.
BPC-157 and GLP-1 longevity research: overlapping mechanisms in metabolic health, cellular repair, mitochondrial function and preclinical anti-aging data.
GLP-1 research compounds vs oral semaglutide: preclinical mechanism comparison, bioavailability data, and what laboratory models show about each compound class.
GLP-1 research compounds explained: native GLP-1, Retatrutide, and Orforglipron. Mechanisms, research applications, and oral capsule delivery. COA verified.
Selank and Semax explained: the Russian nootropic peptides with GABAergic and BDNF mechanisms. Available as oral capsules. 99{bc6192475b1f7ab2a319df0d74882f1947535342342376b459ce77de5d749ac5}+ purity, COA documented.
THE STACK · RESEARCH NOTES
78 papers across 7 compound categories.